U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
9606196061Predicting Steroid Response Using Exhaled Nitric OxideCompletedNo Results AvailableAsthmaOther: 50% step down reduction in inhaled corticosteroid dosehttps://ClinicalTrials.gov/show/NCT01308411
9606296062Prediction and Characterization of Acute and Chronic Postoperative PainCompletedNo Results AvailablePain|Pain, Postoperative|Funnel ChestOther: Conditioned pain modulationhttps://ClinicalTrials.gov/show/NCT01308385
9606396063Cardiovascular Risk in General Practice in France: Cardiovascular Risk WeekCompletedNo Results AvailableHealthyhttps://ClinicalTrials.gov/show/NCT01308372
9606496064Use of Glucose and Saline for Fetal Movement PerceptionRecruitingNo Results AvailableFetal Movement PerceptionDrug: IV glucose 5%|Drug: salinehttps://ClinicalTrials.gov/show/NCT01308359
9606596065ABSORB PHYSIOLOGY Clinical InvestigationTerminatedNo Results AvailableCoronary Artery DiseaseDevice: Bioabsorbable Vascular Solutions Everolimus Eluting Coronary Stent System (BVS EECSS)|Device: XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)https://ClinicalTrials.gov/show/NCT01308346
9606696066Investigation of Chronic Inflammatory Processes in Male Individuals With Hypohidrotic Ectodermal DysplasiaCompletedNo Results AvailableX-linked Hypohidrotic Ectodermal Dysplasiahttps://ClinicalTrials.gov/show/NCT01308333
9606796067Dose-dependent Effect of Fentanyl on Cough Attenuation During Emergence From General AnaesthesiaCompletedNo Results AvailableThyroid NeoplasmDrug: fentanyl citrate|Drug: salinehttps://ClinicalTrials.gov/show/NCT01308320
9606896068Is Non-cycloplegic Photorefraction Applicable for Screening Refractive Risk Factors of Amblyopia?CompletedNo Results AvailableAmblyopiaDevice: photorefractionhttps://ClinicalTrials.gov/show/NCT01308307
9606996069Immunotherapy of HLA-A2 Positive Stage II-IV Melanoma PatientsTerminatedNo Results AvailableMelanomaBiological: 2 vaccine injections in 1 limb|Biological: 2 vaccine injections in different limbs|Biological: 2 vaccine injections in different limbs, the vaccine does not contain the MHC class II peptide MAGE-A3-DP4https://ClinicalTrials.gov/show/NCT01308294
9607096070Impact of IntraVascular UltraSound Guidance on Outcomes of Xience Prime Stents in Long Lesions (IVUS-XPL Study)RecruitingNo Results AvailableCoronary Artery DiseaseProcedure: PCI with IVUS guidance|Procedure: PCI without IVUS guidancehttps://ClinicalTrials.gov/show/NCT01308281
9607196071Management of Soil-transmitted Helminthiasis and StrongyloidiasisRecruitingNo Results AvailableHelminthiasis|Strongyloides Stercoralis InfectionDrug: Ivermectin + Albendazolehttps://ClinicalTrials.gov/show/NCT01308268
9607296072Infliximab as Induction Therapy in Early Rheumatoid Arthritis (IDEA)CompletedNo Results AvailableRheumatoid ArthritisDrug: Infliximab|Drug: Methylprednisolone|Drug: Methotrexate|Dietary Supplement: Folic acidhttps://ClinicalTrials.gov/show/NCT01308255
9607396073Effects of a Non-Calcium Based Phosphate Binder on FGF23 Levels in Chronic Kidney DiseaseRecruitingNo Results AvailableChronic Kidney DiseaseDrug: Sevelamer Carbonatehttps://ClinicalTrials.gov/show/NCT01308242
9607496074Safety and Efficacy Study of the Nile PAX Drug-Eluting Coronary Bifurcation StentCompletedNo Results AvailableCoronary DiseaseDevice: Nile PAX® paclitaxel-eluting coronary stenthttps://ClinicalTrials.gov/show/NCT01308229
9607596075Transcranial Laser Therapy in the Rehabilitation of Hemiplegic Patients From Ischemic StrokeTerminatedNo Results AvailableHemiplegiaProcedure: low level laser therapy procedurehttps://ClinicalTrials.gov/show/NCT01308216
9607696076Lipid Efficacy of the Extended Release Niacin/Laropiprant Combination in Patients With Cardiovascular DiseaseTerminatedNo Results AvailableCoronary Artery Disease|DyslipidemiasDrug: Extended release niacin/laropiprant|Drug: placebohttps://ClinicalTrials.gov/show/NCT01308203
9607796077Preoperative Chemoradiotherapy and Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in T2-T3s N0, M0 Rectal CancerRecruitingNo Results AvailableRectal CancerDrug: Capecitabine (Xeloda)|Radiation: 50.4 Gy|Procedure: Transanal Endoscopic Microsurgery|Procedure: Total Mesorectal Excisionhttps://ClinicalTrials.gov/show/NCT01308190
9607896078Efficacy of Ecabet Sodium and Proton Pump Inhibitor Combination Therapy in the Treatment of Iatrogenic Ulcer After Endoscopic Submucosal DissectionEnrolling by invitationNo Results AvailableDelayed Bleeding,|Healing Ulcer|Quality of UlcerDrug: Ecabethttps://ClinicalTrials.gov/show/NCT01308177
9607996079MD Logic Pump Advisor -Pediatric StudyActive, not recruitingNo Results AvailableType 1 DiabetesDevice: MD Logic Pump Advisorhttps://ClinicalTrials.gov/show/NCT01308164
9608096080Culturally Adapted Cognitive Behavioral Therapy for Prevention of Self HarmCompletedNo Results AvailableAttempted Suicide|DepressionOther: Otherhttps://ClinicalTrials.gov/show/NCT01308151
9608196081Myocardial Physiology And Microanatomy In Individuals Undergoing Heart SurgeryCompletedNo Results AvailableMyocardial InjuryBehavioral: Exercise training|Procedure: remote ischemic preconditioninghttps://ClinicalTrials.gov/show/NCT01308138
9608296082Safety And Feasibility Study Of Pressure-controlled Intermittent Coronary Sinus Occlusion (PICSO) In Patients With Coronary Artery Disease Undergoing Native Vessel InterventionCompletedNo Results AvailableStable AnginaProcedure: PICSOhttps://ClinicalTrials.gov/show/NCT01308125
9608396083Prenatal Iron and Malaria StudyCompletedNo Results AvailableMalariaDietary Supplement: ironhttps://ClinicalTrials.gov/show/NCT01308112
9608496084Assessment of Vascular Endothelial Function in Postural Tachycardia SyndromeRecruitingNo Results AvailablePostural Tachycardia SyndromeDevice: Blood Pressure and Blood Flowhttps://ClinicalTrials.gov/show/NCT01308099
9608596085Adjuvant Therapy(3 vs. 6 Months) With the FOLFOX 4 or XELOX for Stage II or Stage III Colon CancerRecruitingNo Results AvailableCRCDrug: 5-Fluorouracil|Drug: Leucovorin|Drug: Oxaliplatin|Drug: Capecitabine|Drug: Oxaliplatin|Drug: 5-Fluorouracil|Drug: Leucovorin|Drug: Capecitabine|Drug: Oxaliplatin|Drug: Oxaliplatinhttps://ClinicalTrials.gov/show/NCT01308086
9608696086Stability of Middle Molecule ClearanceCompletedNo Results AvailableContinuous HemodialysisDevice: Hemodialysis with EMIC 2 filtershttps://ClinicalTrials.gov/show/NCT01308073
9608796087A Multi-Center Study Of CD07743 for the Improvement of Lateral Canthal Lines (CROW'S FEET)CompletedNo Results AvailableCanthal LinesDrug: Botulinum Toxin Type Ahttps://ClinicalTrials.gov/show/NCT01308060
9608896088Comparing Heavy Levobupivacaine With Enantiomeric Excess of 50% and Heavy Racemic Bupivacaine.WithdrawnNo Results AvailableFracture of Lower LimbDrug: Bupivacainehttps://ClinicalTrials.gov/show/NCT01308047
9608996089Study of Continuous Dosing of Sunitinib in Non GIST Sarcomas With Concomitant RadiotherapyRecruitingNo Results AvailableNon GIST SarcomasDrug: sunitinibhttps://ClinicalTrials.gov/show/NCT01308034
9609096090Clinical Efficacy and Safety of gpASIT+TM to Treat Seasonal Allergic RhinoconjunctivitisCompletedNo Results AvailableGrass Pollen Allergy|Hay FeverBiological: gpASIT+TM|Biological: gpASIT+TM|Biological: Placebohttps://ClinicalTrials.gov/show/NCT01308021

* Görseller ve İçerik tekif hakkına sahip olabilir